Meningococcemia with vitreous opacities: endophthalmitis or vitreous hemorrhage?
Shappell
K K
KK
Gehrs
K M
KM
Keech
R V
RV
Cannon
T C
TC
Folberg
R
R
D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D002439:Cefotaxime / Q000627:therapeutic use; D002675:Child, Preschool; D004211:Disseminated Intravascular Coagulation / Q000150:complications / Q000473:pathology; D009877:Endophthalmitis / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D015818:Eye Infections, Bacterial / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008589:Meningococcal Infections / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D009345:Neisseria meningitidis / Q000302:isolation & purification; D014821:Vitrectomy; D014822:Vitreous Body / Q000382:microbiology* / Q000473:pathology; D014823:Vitreous Hemorrhage / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology
D002439:Cefotaxime